Latest News

2011

June 27       Clinical Trial Probability of Success? Just How Probable Is A Great Outcome.

June 20       Clinical Trial Success: How Do You Define Success?

June 13        CLINICAL DEVELOPMENT: CLINICAL TRIAL DATA MANAGEMENT, STATISTICAL PROGRAMMING AND ANALYSIS, AND QUALITY ASSURANCE

June 6          CLINICAL DEVELOPMENT: THE CLINICAL TRIAL CASE REPORT FORM AND CLINICAL TRIAL MONITORING 

May 30         Ensuring Clinical Trial Data Quality

May 23         11 Considerations in Choosing the Right Clinical Trial Sites 

May 16          Clinical Development: The Clinical Trial Sample Size

May 9            Clinical Development: Clinical Trial Design

May 2            Clinical Development: The Clinical Trial Protocol Patient Population 

April 25        Clinical Development: The Clinical Trial Protocol

April 19         Clinical Trials: The Clinical Development Plan Part 2

April 11          Clinical Trials: The Clinical Development Plan Pt 1

April 4           Clinical Trials: Crafting the Label

March 28      Clinical Trials: Three Dimensions of Success

March 21       Clinical Trials in the USA for Ex-USA Companies

March 14       5 Commercial Considerations of Clinical Trial End Points and Measures

March 7         Placebo-Controlled Clinical Trials. Are They Still Relevant?

February 28  Clinical Trial End Points At Different Phases of Clinical Development

February 21   Clinical Trial Efficacy End Points: What to choose?

February 15   3 Phase 1 Clinical Study Oncology Dilemmas for Sponsors

February 7     4 Missteps in Phase 2 Clinical Studies

January 31      BioStrategics Consulting Ltd Consulting Experiences and Ideal Business Clients.

January 24      New FDA Clinical Study Safety Monitoring Requirements

January 17       BioStrategics Consulting Ltd explains some of its Clinical Development Services

January 12        “Doing it Right” in Phase 2 Clinical Trials

January 10        BioStrategics Consulting Ltd Introduces its President and Senior Clinical Development Consultant, Michael H. Silverman, MD, FACP.

January 4          Dr Michael Silverman, principal of BioStrategics Consulting Ltd announces the launch of a New Blog Site for Companies Contemplating Clinical Development of Their Medical Products.

Copyright © 2011 BioStrategics Consulting Ltd.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s